Send a Tweet
Most Popular Choices
Share on Facebook 2 Share on Twitter Printer Friendly Page More Sharing
General News    H4'ed 10/30/17

Pharma Founder Arrested, Charged with Alleged Opioid Scheme

Quicklink Submitted By     (# of views)   9 comments
Follow Me on Twitter     Message Meryl Ann Butler
Become a Fan
  (83 fans)

Bribes
Bribes
(Image by Damian Gadal)
  Details   DMCA

John Kapoor, former CEO of Insys Therapeutics, has been charged with conspiring to push the company's signature drug for unacceptable uses through a series of bribes and kickbacks. Subsys, as the drug is known, transmits the extremely powerful narcotic fentanyl in spray form, allowing it to be placed beneath the tongue for fast, potent pain relief. It is meant only for treating cancer patients suffering from severe pain.But according to prosecutors, Kapoor and several other former high-ranking executives at the company conspired to bribe doctors to write 'large numbers of prescriptions for the patients, most of whom were not diagnosed with cancer.' 

Read the rest of the story HERE:

At www.npr.org

 

Must Read 3   Valuable 2   Supported 1  
Rate It | View Ratings

Meryl Ann Butler Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Meryl Ann Butler is an artist, author, educator and OpedNews Managing Editor who has been actively engaged in utilizing the arts as stepping-stones toward joy-filled wellbeing since she was a hippie. She began writing for OpEdNews in Feb, 2004. She became a Senior Editor in August 2012 and Managing Editor in January, (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)